GJB3
protein-codinggap junction protein beta 3, the group of Gap junction proteins
Gene summary
This gene is a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. Mutations in this gene can cause non-syndromic deafness or erythrokeratodermia variabilis, a skin disorder. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]
- DFNA2
- EKV
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~5.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0015351
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0033010
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0033010
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0033010
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0033010
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009076
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0009076
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0033010
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0009076
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0033010
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0019588
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0033010
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0019587
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0017851
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0019497
Submitter: ClinGen
The GJB3 gene has been associated with autosomal dominant nonsyndromic hearing loss using the ClinGen Clinical Validity Framework as of 3/7/2017. This association was made using case-level data only. Multiple missense and nonsense variants have been reported in humans, however many of these variants are present in high frequency in population databases and/or have no evidence for pathogenicity. 3 variants were considered to have enough evidence to score. GJB3 was first associated with this disease in humans as early as 1998 (Xia et al.). Association is seen in at least 5 probands in 3 publications (12759707, 19744334, 22617145). This gene-disease association is supported by expression studies in rat and mouse cochlea. Of note, this gene has also been implicated in Erythrokeratodermia variabilis. This has been assessed separately. In summary, there is convincing evidence disputing the association between GJB3 and autosomal dominant nonsyndromic hearing loss. More evidence is needed to either support or refute the role GJB3 plays in this disease. This classification was approved by the ClinGen Hearing Loss Working Group on 2/27/2018.
Inheritance Pattern: AD
Disease ID:MONDO:0017851
Submitter: ClinGen
The *GJB3* gene was first associated with autosomal dominant erythrokeratodermia variabilis (EKV) in 1998 (Richard et al., PMID: 9843209). At least 12 unique missense variants have been reported in 22 probands in 18 publications (PMIDs: 9843209, 10594760, 10798362, 15948974, 18482034, 21879244, 21188847, 22681493, 23442023, 26632638, 25297803, 21950330, 20497287, 25556823, 31912549, 31793497, 35663771, 35677558). Some variants are reported de novo, however paternity and maternity were not confirmed in most cases. Variants in this gene segregated with disease in 17 additional members in two families (PMIDs: 9843209, 10594760). This gene-disease relationship is also supported by mouse and zebrafish models which have recapitulated partial phenotypes of EKV, and several functional alteration studies (PMIDs: 12176042, 21920315, 22393412, 26251042). Of note, this gene has also been implicated in autosomal dominant nonsyndromic hearing loss which has been assessed separately as Disputed. In summary, there is definitive evidence to support the relationship between *GJB3* and autosomal dominant erythrokeratodermia variabilis. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This gene-disease pair was originally evaluated as Strong by the ClinGen Hearing Loss Working Group on 3/5/2018 as per SOP v6. It was reevaluated on 6/1/2023 as per SOP v9. As a result of this reevaluation, the classification increased from Strong to Definitive due to additional case level evidence from new publications (PMIDs: 31912549, 31793497, 35663771, 35677558).
Inheritance Pattern: Unknown
Disease ID:MONDO:0012976
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0033010
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Dermatologic; Neurologic
Intervention: Audiologic/Otolaryngologic
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development
Comments: Digenic inheritance (with GJB2) has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GJB3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_024009.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 36 | 2 | 40 | ||
| missense | 5 | 6 | 124 | 15 | 2 | 152 |
| nonsense | 1 | 1 | 9 | 11 | ||
| start loss | 1 | 1 | ||||
| frameshift | 7 | 7 | ||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 6 | 7 | 143 | 51 | 4 | 211 |
Highest pathogenic variant AF is 0.00024162371
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_076872.1 | 1 | MANE Select | |
| Ensembl | ENSP00000362464.2 | 1 | MANE Select | |
| RefSeq | NP_001005752.1 | 1 | Standard | |
| Ensembl | ENSP00000362460.3 | 1 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Calcium Regulation in the Cardiac Cell
Biological Process
- in utero embryonic development
- placenta development
- cell communication
- spermatogenesis
- skin development
Molecular Function
- gap junction channel activity
Cellular Component
- cytoplasm
- gap junction
- connexin complex
- integral component of membrane
- cell junction
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000373366
- Coding exons
- 1
- Length
- 5181
- Individuals with no LoFs
- 125690
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 58
- Defined
- 125748
- p
- 0.000231
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.526 | 187 | 168 | 1.11 | 0.0000121 | 1742 |
| Missense (PolyPhen) | 92 | 85.298 | 1.0786 | 921 | ||
| Synonymous | 0.885 | 65 | 74.7 | 0.870 | 0.00000573 | 565 |
| Loss of Function | 0.958 | 5 | 7.91 | 0.632 | 4.37e-7 | 72 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.0014 | 0.0014 | notable |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00012 | 0.00012 | rare |
| South Asian | 0.00036 | 0.00036 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell.;
- Disease
- DISEASE: Erythrokeratodermia variabilis et progressiva 1 (EKVP1) [MIM:133200]: A form of erythrokeratodermia variabilis et progressiva, a genodermatosis characterized by the coexistence of two independent skin lesions: transient erythema and hyperkeratosis that is usually localized but occasionally occurs in its generalized form. Clinical presentation varies significantly within a family and from one family to another. Palmoplantar keratoderma is present in around 50% of cases. {ECO:0000269|PubMed:10594760, ECO:0000269|PubMed:10798362, ECO:0000269|PubMed:9843209}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal dominant, 2B (DFNA2B) [MIM:612644]: A form of non-syndromic sensorineural deafness characterized by progressive high frequency hearing loss in adulthood, with milder expression in females. {ECO:0000269|PubMed:9843210}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.164
Intolerance Scores
- LoFtool
- 0.107
- RVIS EVS
- 0.2
- RVIS percentile EVS
- 67.3
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.156
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |